Dr. Shimon Eckhouse
Chairman of the Board of Directors
Director Since: 2004
Dr. Shimon Eckhouse is a co-founder of Syneron and a co-developer of the proprietary elos technology on which Syneron’s aesthetic medical devices are based. Dr. Eckhouse was also the inventor and developer of IPL technology, another fundamental cornerstone of non-invasive aesthetic medical devices. In addition to serving as active chairman at Syneron, Dr. Eckhouse is also the chairman and co-founder of CardioDex Ltd., NanoCyte Ltd., Navotek Ltd., Tulip Ltd., Rapid Medical Ltd., Opticul Diagnostic Ltd., RealView Ltd. and the Chairman of Orsense Ltd. Dr. Eckhouse was a co-founder of ColorChip and has served as its chairman and CEO from 2001 to 2003. He was a co-founder of Ventor Medical Technologies Ltd. and served as its Chairman until it was acquired by Medtronic in February 2009. Dr. Eckhouse was the chairman and CEO of ESC Medical Systems from its inception in 1992 until 1999. He also previously worked at Rafael, Armament Development Authority of Israel as a scientist, team leader and head of department and was active in various areas of R&D including lasers and electro-optics. Dr. Eckhouse holds a B.Sc. in physics from the Technion Israeli Institute of Technology and a Ph.D. in physics from the University of California at Irvine. He has more than 20 registered patents and published more than 50 papers in leading reference journals and conferences. He is also a member of the Board of Directors of the Technion Israeli Institute of Technology.
|
David Schlachet
Independent Director / External Director
Director Since: 2007
David Schlachet has been a member of the Board of Directors of Syneron since May 14, 2007. Mr. Schlachet joined Syneron in 2004 as CFO and was appointed as CEO in November 2005. Prior to his joining Syneron, Mr. Schlachet was a managing partner of Biocom, a venture capital fund specializing in life sciences. In the broader technology and biotech area, Mr. Schlachet was Vice President of Finance and Administration of the Weizmann Institute of Science, Israel’s premier post-graduate scientific research institute. Mr. Schlachet also has held senior managerial positions in major Israeli corporations such as Strauss Elite Holdings, one of Israel’s largest packaged food groups, where he served as CFO, and Elite Industries, one of Israel’s largest chocolate and confectionary manufacturers, where he was active chairman. Mr. Schlachet currently serves as a director for Nasdaq listed EzChip (formerly LanOptics Ltd.), as well as for Tel-Aviv Stock Exchange listed companies Taya Investments Ltd., Mazor Surgical Technologies Ltd. and Edgar Investments and Developments Ltd., as well as a director of several privately owned Israeli companies. Mr. Schlachet holds a B.Sc. degree in chemical engineering and an M.B.A. from the Tel-Aviv University
|
Dan Suesskind
Independent Director / External Director
Director Since: 2004
Dan Suesskind is the Chief Financial Officer of Teva Pharmaceutical Industries Ltd., the largest generic drug company in the world, a position he has held since 1978. He served as a director of Teva until 2001 and is currently a member of the Jerusalem Foundation Investment Advisory Committee, the Board of Trustees of Hebrew University, Migdal Insurance Company, and Ness Technologies Inc.
|
Michael Anghel
Independent Director / External Director
Director Since: 2004
Dr. Michael Anghel is the President and CEO of the Israel Discount Capital Markets and Investments Corp. Previously, he established CAP Ventures, which invested in and established several IT and communications enterprises. Earlier, he was senior director of IDB-Discount Investment Corporation. Dr. Anghel served as director of numerous companies, including DIC, Elbit, Elron, Elscint, AIPM and Orbotech.
|
Marshall Butler
Independent Director / External Director
Director Since: 2003
Marshall Butler has served as a director since October 2003. Mr. Butler is a co-founder and has served as a chairman of both First Israel Mezzanine Investors Fund and Israeli Infinity VC Fund since 1996. Mr. Butler is currently a director of Tadiran Telecommunications Ltd., Shellcase, Galil Medical Ltd., New York State Council of Humanities and A.R.T. New York. Mr. Butler served as chairman of Nitzanim, AVX-Kyocera VC from 1994 to 2001. Mr. Butler served as CEO and chairman of AVX Corporation from 1974 to 1993 and as director of Kyocera VC from 1990 to 1994. Mr. Butler is on the Board of Governors of the Technion Institute in Haifa, Israel. In 1998, Mr. Butler received the Israeli Prime Minister's award for his contribution to Israeli industry. In 2001, he received an Honorary Doctorate from the Technion Institute.
|
Yaffa Krindel
Independent Director / External Director
Director Since: 2005
Yaffa Krindel was appointed to the Board of Syneron in November 2005. Ms. Krindel is a Partner and Investment Manager of Star Ventures, one of Israel's largest venture capital funds, where she has made investments in IT and medical device companies in Israel. Ms Krindel has served as CFO and VP Finance in two Israeli technology companies and as Corporate Treasurer in one of Israel's largest chemical producers. Ms. Krindel currently serves on the board of directors of one other publically traded company, Fundtech, as well as privately held start ups including Broadlight Inc., Siano Mobile Communications, Negevtech, and OrSense Ltd.
|
Dominick Arena
Independent Director / External Director
Director Since: 2012
Dominick Arena was appointed to the Board of Syneron in March 2012. Mr. Arena currently serves as an operating partner with Water Street Healthcare Partners, a strategic private equity firm focused exclusively on the healthcare industry. Previously, Mr. Arena was President of Smiths Critical Care, a division of Smiths Medical. He joined Smiths Medical after the company acquired Medex Inc., where he served as President and Chief Executive Officer. Prior to this, Mr. Arena led the Healthcare division of the Furon Company, and served as the leader of three medical device manufacturers: AnaMed International, Hudson Respiratory Care, and Respiratory Care, Inc. He also previously held positions at The Kendall Corporation and Baxter International Inc.Mr. Arena currently serves on the Boards of Directors of Sigma International, US Endoscopy, and The Legacy Foundation. He previously served on the Boards of Alpine Biomed and Facet Technologies. Mr. Arena received a Bachelors of Science in Chemistry from Le Moyne College.
|
|
